Affiliation:
1. Zhejiang Chinese Medical University, Hangzhou, China
2. Tokyo Yushi Health Institute, Tokyo, Japan
3. The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Abstract
Background:
Primary osteoporosis (POP) is one of the most common orthopedic conditions with a high risk of fractures. Effective treatment of POP is crucial for reducing disability rates and improving quality of life. Kidney tonic therapy is a classical traditional Chinese medicine approach for treating POP. This study aims to provide a comprehensive and reliable assessment of the clinical evidence of kidney tonic herbs (KTH) in treating POP patients.
Methods:
An extensive literature search was conducted in 8 electronic databases from their inception through September 30, 2022, to evaluate the efficacy and safety of KTH for POP. We included 43 randomized controlled trials with 4349 participants. The qualified studies will be chosen and evaluated separately by 2 researchers. The primary outcome measure was bone mineral density (BMD) of lumbar. RevMan 5.3 and Stata 16 were used to carry out the meta-analyses.
Results:
Our meta-analysis showed 29 studies with significantly increased lumbar BMD (mean difference [MD] = 0.06; 95% confidence interval [CI]; I
2 = 98%, P = .003), 18 studies with noticeably higher femoral neck BMD (MD = 0.08; 95% CI; I
2 = 98%, P = .0005), 6 studies with significantly increased femoral trochanter BMD (MD = 0.10; 95% CI; I
2 = 97%, P = .002), 4 studies with noticeably higher ward’s triangle BMD (MD = 0.13; 95% CI; I
2 = 100%, P = .04), and 3 studies with noticeably higher distal radius BMD (MD = 0.06; 95% CI; I
2 = 86%, P = .009). One study showed 12 falls and 8 fallers in the intervention group, 28 falls and 17 fallers in the control group at 36 months. 3 studies showed a significant difference in fracture incidence between the intervention group and the control group (95% CI: 0.15-0.81; I
2 = 0%, P = .01). Additionally, the meta-analysis demonstrated that KTH offered superior pain relief (8 trials, n = 980; 95% CI: −1.05 to −0.74; I
2 = 94%, P < .00001). Besides, KTH found no serious harmful effects.
Discussion:
KTH may increase BMD and decrease the likelihood of fractures in POP patients. However, further research is necessary to investigate the effectiveness of KTH in reducing falls and fractures.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference76 articles.
1. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians.;Qaseem;Ann Intern Med,2017
2. Guidelines for the diagnosis and management of primary osteoporosis (2017).;Xia;Chin J Osteoporos,2019
3. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study.;Wang;JAMA Netw Open,2021
4. UK clinical guideline for the prevention and treatment of osteoporosis.;Gregson;Arch Osteoporos,2022
5. Traditional Chinese medicine expert consensus on the prevention and treatment of primary osteoporosis (2020).;Ge;Chin J Osteoporos,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献